Mindray Medical (MR) Tops Q3 EPS by 6c; Revs Light
Mindray Medical International Limited (NYSE: MR) reports Q3 EPS of $0.33, 6 cents better than estimates. Revenues were $151.1 million vs. $154.98 million consensus.
[SM]
[SM]
You May Also Be Interested In
- UPDATE: Bristow Group (BRS) Reports Better-Than-Expected Q4 Results; Offers FY13 Outlook
- UPDATE: NetApp, Inc. (NTAP) Tops Q4 EPS by 3c; Guides Q1 Lower
- Taro Pharmaceutical Industries (TARO) Nearly Doubles Q1 EPS to 1.06
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
